BOSTON (Reuters) - Valeant Pharmaceuticals International Inc can pay "substantially" more for Allergan Inc and should get a fair shot at buying it, William Ackman, the Botox maker's biggest shareholder, said on Friday.


from Reuters: Business News http://ift.tt/1tljPg4
Tidak ada komentar:
Posting Komentar